Phase 3 Vasodilatory shock Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Not Yet Recruiting
Phase 3
Early Adjunctive Vasopressin for Vasodilatory Shock - A Stepped Wedge Vanguard Feasibility Trial: The EAVES Study
Refractory hypotensionVasodilatory shock
Austin Health - Dr. Heidi Gaulke1,000 enrolled1 locationACTRN12626000338369
Recruiting
Phase 3
Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
Vasodilatory shock
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.214 enrolled42 locationsNCT06351150